Suchergebnisse - "Pinato, David J"

PubPharm (75)

1

Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types : a systematic review

enthalten in: Journal for immunotherapy of cancer | 2024

von Galle, P. | Finn, R. | Mitchell, C. | +4

2

Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram

enthalten in: Frontiers in immunology | 2024

von Losurdo, A. | Dipasquale, A. | Giordano, L. | +11

3

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy : A global, observational study

enthalten in: Hepatology communications | 2023

von Joerg, V. | Scheiner, B. | D Alessio, A. | +33

4

Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer

enthalten in: Journal for immunotherapy of cancer | 2023

von Naqash, A. | McCallen, J. | Mi, E. | +22

5

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC) : "Real World" Experience

enthalten in: Clinical genitourinary cancer | 2023

von Bakaloudi, D. | Talukder, R. | Lin, G. | +32

6

Diabetes and Immune Checkpoint Inhibitors-Response

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Cortellini, A. | D'Alessio, A. | Pinato, D.

CommentOn: Clin Cancer Res. 2023 Jul 14;29(14):2714-2724. - PMID 37125965

7

Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer

enthalten in: Cell reports. Medicine | 2023

von Lu, H. | Lou, H. | Wengert, G. | +14

8

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Cortellini, A. | D'Alessio, A. | Cleary, S. | +55

CommentIn: Clin Cancer Res. 2023 Oct 2;29(19):4017-4018. - PMID 37779446

9

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Alessi, J. | Elkrief, A. | Ricciuti, B. | +25

CommentIn: J Thorac Oncol. 2023 Jun;18(6):682-685. - PMID 37210177

10

A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Chen, M. | Lu, H. | Copley, S. | +7

CommentIn: J Thorac Oncol. 2023 Jun;18(6):686-688. - PMID 37210178

1
2
3
4
5
6
7
8
Nächster »
[8]